Jay S Shavadia1, Anita Y Chen2, Alexander C Fanaroff2, James A de Lemos3, Michael C Kontos4, Tracy Y Wang2. 1. Duke Clinical Research Institute, Durham, North Carolina; Division of Cardiology, Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Electronic address: jay.shavadia@duke.edu. 2. Duke Clinical Research Institute, Durham, North Carolina. 3. Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas. 4. Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.
Abstract
OBJECTIVES: The aims of this study were to describe variability in intensive care unit (ICU) utilization for patients with uncomplicated ST-segment elevation myocardial infarction (STEMI), evaluate the proportion of these patients who developed in-hospital complications requiring ICU care, and assess whether ICU use patterns and complication rates vary across categories of first medical contact to device times. BACKGROUND: In the era of rapid primary percutaneous coronary intervention, ICUs may be overutilized as patients presenting with STEMI are less likely to develop complications requiring ICU care. METHODS: Using data from the Chest Pain-MI Registry linked to Medicare claims, the authors examined patterns of ICU utilization among hemodynamically stable patients with STEMI ≥65 years of age treated with uncomplicated primary percutaneous coronary intervention, stratified by timing of reperfusion: early (first medical contact-to-device time ≤60 min), intermediate (61 to 90 min), or late (>90 min). RESULTS: Of 19,507 patients with STEMI treated at 707 hospitals, 82.3% were treated in ICUs, with a median ICU stay of 1 day (interquartile range [IQR]: 1 to 2 days). The median FMC-to-device time was 79 min (IQR: 63 to 99 min); 22.0% of patients had early, 44.8% intermediate, and 33.2% late reperfusion. ICU utilization rates did not differ between patients with early, intermediate, and late reperfusion times (82%, 83%, and 82%; p for trend = 0.44). Overall, 3,159 patients (16.2%) developed complications requiring ICU care while hospitalized: 3.7% died, 3.7% had cardiac arrest, 8.7% shock, 0.9% stroke, 4.1% high-grade atrioventricular block requiring treatment, and 5.7% respiratory failure. Patients with longer FMC-to-device times were more likely to develop at least 1 of these complications (early 13.4%, intermediate 15.7%, and late 18.7%; p for trend <0.001; adjusted odds ratio [early as reference] for intermediate: 1.13 [95% confidence interval: 1.01 to 1.25]; adjusted odds ratio for late: 1.22 [95% confidence interval: 1.08 to 1.37]). CONCLUSIONS: Although >80% of stable patients with STEMI are treated in the ICU after primary percutaneous coronary intervention, the risk for developing a complication requiring ICU care is 16%. Implementing a risk-based triage strategy, inclusive of factors such as degree of reperfusion delay, could optimize ICU utilization for patients with STEMI.
OBJECTIVES: The aims of this study were to describe variability in intensive care unit (ICU) utilization for patients with uncomplicated ST-segment elevation myocardial infarction (STEMI), evaluate the proportion of these patients who developed in-hospital complications requiring ICU care, and assess whether ICU use patterns and complication rates vary across categories of first medical contact to device times. BACKGROUND: In the era of rapid primary percutaneous coronary intervention, ICUs may be overutilized as patients presenting with STEMI are less likely to develop complications requiring ICU care. METHODS: Using data from the Chest Pain-MI Registry linked to Medicare claims, the authors examined patterns of ICU utilization among hemodynamically stable patients with STEMI ≥65 years of age treated with uncomplicated primary percutaneous coronary intervention, stratified by timing of reperfusion: early (first medical contact-to-device time ≤60 min), intermediate (61 to 90 min), or late (>90 min). RESULTS: Of 19,507 patients with STEMI treated at 707 hospitals, 82.3% were treated in ICUs, with a median ICU stay of 1 day (interquartile range [IQR]: 1 to 2 days). The median FMC-to-device time was 79 min (IQR: 63 to 99 min); 22.0% of patients had early, 44.8% intermediate, and 33.2% late reperfusion. ICU utilization rates did not differ between patients with early, intermediate, and late reperfusion times (82%, 83%, and 82%; p for trend = 0.44). Overall, 3,159 patients (16.2%) developed complications requiring ICU care while hospitalized: 3.7% died, 3.7% had cardiac arrest, 8.7% shock, 0.9% stroke, 4.1% high-grade atrioventricular block requiring treatment, and 5.7% respiratory failure. Patients with longer FMC-to-device times were more likely to develop at least 1 of these complications (early 13.4%, intermediate 15.7%, and late 18.7%; p for trend <0.001; adjusted odds ratio [early as reference] for intermediate: 1.13 [95% confidence interval: 1.01 to 1.25]; adjusted odds ratio for late: 1.22 [95% confidence interval: 1.08 to 1.37]). CONCLUSIONS: Although >80% of stable patients with STEMI are treated in the ICU after primary percutaneous coronary intervention, the risk for developing a complication requiring ICU care is 16%. Implementing a risk-based triage strategy, inclusive of factors such as degree of reperfusion delay, could optimize ICU utilization for patients with STEMI.
Authors: John Z Nan; Jacob C Jentzer; Robert C Ward; Rachel J Le; Megha Prasad; Gregory W Barsness; Rajiv Gulati; Gurpreet S Sandhu; Malcolm R Bell Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2021-11-26
Authors: Jason N Katz; Shashank S Sinha; Carlos L Alviar; David M Dudzinski; Ann Gage; Samuel B Brusca; M Casey Flanagan; Timothy Welch; Bram J Geller; P Elliott Miller; Sergio Leonardi; Erin A Bohula; Susanna Price; Sunit-Preet Chaudhry; Thomas S Metkus; Connor G O'Brien; Alessandro Sionis; Christopher F Barnett; Jacob C Jentzer; Michael A Solomon; David A Morrow; Sean van Diepen Journal: J Am Coll Cardiol Date: 2020-04-16 Impact factor: 24.094
Authors: Adriana C Luk; Eduard Rodenas-Alesina; Fernando L Scolari; Vicki N Wang; Darshan H Brahmbhatt; Alexandra G Hillyer; Nikki Huebener; Nicole Fung; Madison Otsuki; Christopher B Overgaard Journal: CJC Open Date: 2022-06-18
Authors: Jaihoon Amon; Graham C Wong; Terry Lee; Joel Singer; John Cairns; Jay S Shavadia; Christopher Granger; Kenneth Gin; Tracy Y Wang; Sean van Diepen; Christopher B Fordyce Journal: J Am Heart Assoc Date: 2022-09-03 Impact factor: 6.106
Authors: John J Lopez; Joseph E Ebinger; Sorcha Allen; Mehmet Yildiz; Timothy D Henry Journal: Catheter Cardiovasc Interv Date: 2020-06-01 Impact factor: 2.585